Das Kinderwunsch Institut Schenk

What Das Kinderwunsch Institut Schenk does

Das Kinderwunsch Institut Schenk GmbH is a privately-held, family-run fertility clinic founded in 1999 by Dr. Michael Schenk and Claudia Schenk-Hauschka, headquartered in Dobl near Graz, Austria. The clinic provides a comprehensive reproductive medicine service offering spanning initial consultation, fertility diagnostics (semen analysis, hormone testing, ERA/EMMA/ALICE molecular receptivity and microbiome tests, EMBRACE non-invasive embryo DNA testing), and treatment modalities including IVF, ICSI, intrauterine insemination, TESE/TESA, cryotransfer, and laser-assisted hatching. It operates a certified egg and sperm bank (the first certified egg cell bank in Austria since 2015) and the in-house FRED research institute focused on reproductive medicine. Technology differentiation rests on time-lapse embryo monitoring (Geri and Embryoscope+ incubators capturing images every minute), Cryotop vitrification cooling cells to -196°C, Polaraide polarized-light egg assessment, and proprietary digital tools including the FertiBot chatbot.

The clinic serves heterosexual and same-sex couples facing infertility, women requiring medically indicated fertility preservation, and (from April 2027) women seeking elective social egg freezing. Geographic reach is anchored to a 3-hour car radius around Graz but is extended nationwide via telemedicine consultations. Marketing is multi-channel and content-led through the Kinderwunsch TV blog, newsletter, Facebook and Instagram, the Glückskinder community association, and the FertiBot digital triage funnel.

The business model is per-cycle and per-procedure transaction fees for treatments and diagnostics, supplemented by cryobank storage fees and a modest recurring revenue stream from Glückskinder association membership (€50 initial fee, €20 annual renewal). Pricing is not publicly disclosed at the treatment level; the Austrian IVF fund subsidizes 70% of IVF/ICSI costs for qualifying diagnoses, with patients paying the residual 30% out of pocket. Strategic targets stated in company documentation include 400+ term pregnancies per year and a 30% EBIT margin to sustain commercial independence. The clinic is privately held with no external investors, no parent company, and no subsidiaries.

Name

Das Kinderwunsch Institut Schenk

Legal name

Das Kinderwunsch Institut Schenk GmbH

Website

https://kinderwunsch-institut.at

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Das Kinderwunsch Institut Schenk is a family-run Austrian fertility clinic in Dobl (near Graz) offering IVF, ICSI, egg/sperm banking, and advanced diagnostics including ERA/EMMA/ALICE, serving couples with fertility challenges in southern Austria.

Ownership category

akta.pro rank

Product category

Reproductive Medicine / Fertility Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

Keywords

• Fertility treatments
• Reproductive medicine
• IVF services
• Fertility diagnostics
• Cryopreservation services

Headquarters

HQ city

Dobl

HQ country

Austria

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Fertility Treatment Services: Revenue from comprehensive fertility treatments including IVF, ICSI, egg donation, sperm donation, cryotransfer, and related medical procedures. Treatments are billed per cycle or procedure with significant portion covered by Austrian IVF fund (70% for qualifying diagnoses).
2. Diagnostic Services: Revenue from fertility diagnostics including semen analysis (spermiogram), hormone testing, ultrasound examinations, cycle monitoring, and specialized tests (ERA, EMMA, ALICE).
3. Egg and Sperm Banking: Revenue from certified egg and sperm bank services including storage and provision of donor materials.
4. Glückskinder Association Membership: Association membership fees: €50 initial (€10 joining fee + €20/year x2), then €20/year renewal. Provides platform for childless and pregnant couples with events and magazine.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Das Kinderwunsch Institut Schenk is a comprehensive reproductive medicine center in Dobl, Austria that provides fertility diagnostics and assisted reproductive treatments including IVF, ICSI, egg and sperm donation, cryotransfer, and cryopreservation. The institute operates a certified egg and sperm bank, runs advanced molecular diagnostic tests (ERA, EMMA, ALICE, EMBRACE), and delivers time-lapse embryo monitoring using Geri/Embryoscope+ incubators. Additional services include the FertiBot digital fertility chatbot, the Initiative 32 fertility-awareness program, and an in-house FRED research institute.

Product overview

Das Kinderwunsch Institut Schenk is a comprehensive reproductive medicine center offering a full spectrum of fertility treatments and diagnostics. The core offerings include IVF, ICSI, egg and sperm banking (cryobank), and cryotransfer. The institute provides advanced molecular diagnostic tests including ERA, EMMA, ALICE, and EMBRACE for personalized embryo transfer optimization. Digital offerings include FertiBot (fertility chatbot) and time-lapse embryo monitoring using Geri/Embryoscope+ technology. The institute operates the FRED research center and maintains ISO 9001 certification since 2002. Additional services encompass osteopathy, psychological support, and the Glückskinder patient association. Social egg freezing will become available from April 2027 following Austrian legal changes.

Differentiator

Problem solved

Functional benefit

Products and services

• In-vitro-Fertilisation (IVF) Fertilization of the egg cell outside the body, where eggs and sperm are combined in a laboratory setting to create embryos, which are then transferred into the uterus. Aimed at couples with various infertility causes.
• Intrazytoplasmatische Spermieninjektion (ICSI) A single sperm is directly injected into the egg cell to facilitate fertilization, particularly for cases of male factor infertility (poor sperm quality or motility). Aimed at couples with severe male factor infertility.
• Eizellbank (Egg Bank) Certified egg cell bank offering donated eggs from carefully selected and qualified donors for couples where the woman cannot produce viable eggs. Aimed at couples requiring donor eggs to achieve pregnancy.
• Samenbank (Sperm Bank) Certified sperm bank providing donated sperm from carefully selected and qualified donors for fertility treatments. Aimed at couples with male factor infertility, single women, and same-sex female couples.
• Kryotransfer (Cryotransfer) Cryopreservation and transfer of frozen embryos using vitrification or Cryotop method, achieving over 90% survival rates. Aimed at patients using previously frozen embryos or eggs.
• Kryokonservierung (Cryopreservation) Freezing and storage of egg cells, sperm cells, and embryos at -196°C using the Cryotop vitrification method for later use. Aimed at patients preserving fertility or storing surplus embryos.
• ERA Test (Endometrial Receptivity Array) Determines optimal timing for embryo transfer by assessing endometrial receptivity after progesterone administration. Personalized transfer increases success rates to 71% within one year. Aimed at patients with repeated implantation failure.
• EMMA Test (Endometrial Microbiome Metagenomic Analysis) Evaluates bacterial DNA profile in the uterine lining (endometrium) to assess microbiome health related to pregnancy success. Aimed at patients with suspected endometrial microbiome imbalance.
• ALICE Test (Analysis of Infectious Chronic Endometritis) Identifies bacteria causing chronic inflammation of the uterine lining associated with infertility and gynecological complications. Aimed at patients with suspected chronic endometritis.
• EMBRACE Cell-free embryonic DNA test that analyzes chromosome count from culture medium without requiring embryo biopsy, enabling non-invasive embryo selection. Aimed at patients seeking genetic screening without invasive procedures.
• FertiBot One of the world's first fertility chatbots providing digital fertility testing for initial assessment in just a few clicks - simple, anonymous and straightforward. Aimed at individuals seeking anonymous initial fertility assessment.
• Spermiogramm (Semen Analysis) Laboratory examination of semen to evaluate sperm count, motility, and morphology for assessing male fertility. Aimed at men undergoing fertility evaluation.
• Follikelmonitoring (Follicle Monitoring) Ultrasound observation of egg maturation and ovulation to determine optimal timing for egg retrieval or insemination. Aimed at women undergoing fertility treatment or natural cycle monitoring.
• Intrauterine Insemination (IUI) Prepared sperm is inserted directly into the uterus at optimal timing, used for mild to moderate sperm quality impairment. Aimed at couples with mild male factor or unexplained infertility.
• TESE/TESA Testicular sperm extraction (TESE) or testicular sperm aspiration (TESA) for obtaining sperm directly from testicles when no sperm are present in ejaculate, used in combination with ICSI. Aimed at men with obstructive or non-obstructive azoospermia.
• Time-Lapse Embryo Monitoring Ultra-modern continuous embryo monitoring using Geri and Embryoscope+ time-lapse incubators, capturing microscopic images every minute for seamless development control without environmental intervention. Aimed at IVF patients seeking enhanced embryo selection.
• Initiative 32 Early fertility awareness program targeting women at age 32 with fertility testing to assess egg reserve and remaining fertile years. Aimed at women in their early 30s proactively assessing fertility status.
• Erstgespräch (Initial Consultation) First appointment designed to get acquainted, answer questions, and assess patient needs before treatment begins. Aimed at all prospective patients starting their fertility journey.
• Verein Glückskinder (Glückskinder Association) Annual membership association for families created through the institute, providing platforms for communication, educational talks, magazine publications, swap exchanges, and annual parties. Aimed at former patients and families in the institute's extended community.
• Polaraide Technology using polarized light to assess maturity and fertilization capability of each egg cell. Aimed at patients undergoing IVF to optimize egg selection.
• Polkörperchen Biopsie (Polar Body Biopsy) Provides genetic information about the egg cell through analysis of polar body cells. Aimed at patients seeking pre-implantation genetic information on egg quality.
• Trophektodermbiopsie (Trophectoderm Biopsy) Cell sampling from the trophectoderm (outer cell layer) of blastocyst-stage embryos for genetic testing. Aimed at patients seeking pre-implantation genetic testing of embryos.
• Transvaginale Hydrolaparoskopie (TVHL) Laparoscopy performed vaginally to examine the pelvic cavity, ovaries, uterus, and fallopian tube patency. Aimed at patients requiring evaluation of pelvic anatomy.
• Laser-Assisted Hatching Laser technology to create an opening in the embryo's shell to facilitate hatching and implantation. Aimed at patients with previous implantation failure or thick embryo shells.

Quantifiable outcome

• Success rate up to 89% with time-lapse embryo culture
• +5 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Five partnerships are on record, tiered minor and core.

• TreeMatesminorStrategic or Co-development PartnerNon-profit reforestation organization based in Graz that coordinates sustainable tree planting in tropical regions. For each positive heartbeat detected in the womb at the institute, and for each digital consultation, one tree is planted. 728 trees already planted through this initiative.
• Meta Platforms (Facebook and Instagram)minorGTM or Marketing PartnerSocial media platforms for patient engagement, educational content distribution, and community building. Institute maintains active profiles on both Facebook and Instagram.
• IgenomixcoreTechnology or IntegrationProvider of ERA, EMMA, and ALICE molecular diagnostic tests for endometrial receptivity and microbiome analysis. Institute uses these proprietary tests for personalized embryo transfer timing.
• Madison WerbeagenturminorImplementation/ SI/ Consulting PartnerCreative advertising agency responsible for website design, concept, and marketing materials.
• UNI for LIFEminorStrategic or Co-development PartnerUniversity continuing education partnership for training young talents in reproductive medicine. Supports medical director's involvement in training specialists.

Scale indicators12 records

Recent moves11 records

Expansion highlights7 records

Direct peers

• Wunschbaby Institut Feichtinger: Vienna-based fertility clinic offering IVF, ICSI, egg and sperm donation, and cryopreservation. Direct competitor to Kinderwunsch Institut Schenk within Austria, targeting similar heterosexual couples, same-sex couples, and fertility preservation patients under the same Austrian regulatory framework.
• Genea: Australia-headquartered fertility clinic group with global operations, offering IVF, ICSI, and preimplantation genetics. Comparable as a vertically integrated fertility operator with proprietary lab technology and research capabilities, though operating under different regulatory regimes.
• Kinderwunschzentrum Goldenes Kreuz: Reproductive medicine center in Vienna providing IVF, ICSI, hormonal treatments, and fertility diagnostics. Comparable in clinical scope, patient demographic, and reliance on the Austrian IVF fund, and directly competes for Styrian and eastern Austrian patients.
• IVF Centers Prof. Zech: Austrian-origin fertility clinic group (now operating across multiple European countries) offering IVF, ICSI, social freezing, and genetic testing. Closest direct competitor in terms of technology stack, egg/sperm bank offerings, and premium positioning in the Austrian IVF market.

Broad incumbents

• CARE Fertility: UK-based fertility clinic network offering IVF, ICSI, genetic testing, and egg/sperm donation. Comparable in service mix and technology adoption (time-lapse, PGT); not a direct Austrian competitor but a relevant benchmark for scaled, multi-site fertility clinic operations.
• Boston IVF: US fertility clinic network offering comprehensive IVF, ICSI, donor services, and fertility diagnostics. Comparable in clinical scope and technology adoption; operates under different regulatory and reimbursement regime but serves as a scaled benchmark for private fertility clinic economics.
• The Lister Fertility Clinic: One of the UK's longest-established fertility clinics, offering IVF, ICSI, donor programs, and fertility preservation. Comparable as a founder-led, brand-rich private fertility clinic with high success rates and a focus on personalized treatment; differs in scale and UK regulatory context.
• IVI-RMA Global: World's largest fertility treatment network (KKR-backed), with clinics across Europe, the Americas, and the Middle East. Comparable in IVF/ICSI/donor services but operates at vastly greater scale; competes for cross-border fertility patients in the broader DACH region.

Others

• Hamilton Thorne: Provider of precision instruments, consumables, and software for the IVF and animal breeding industries. Comparable as a supplier of ART lab equipment used in fertility clinics; enables similar time-lapse and vitrification workflows to those deployed at Kinderwunsch Institut Schenk.
• Vitrolife: Swedish-listed provider of media, devices, and genomic services for IVF clinics. Comparable technology ecosystem (time-lapse, vitrification, PGT) and a key supplier of consumables used by Kinderwunsch Institut Schenk's lab; not a clinic competitor but a relevant industry peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/DasKinderwunschInstitut
• Instagraminstagram.com/daskinderwunschinstitutschenk
• LinkedInlinkedin.com/company/kinderwunsch-institut

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Das Kinderwunsch Institut Schenk